Role of Hemostatic System in Cancer, Inflammation and Immunity » Platelets and Cancer

Abstract Number: PB0751

A Role of Possible Synergistic Effect of P Selectin Glycoprotein Ligand 1 Polymorphism and Antiphosholipid Antibodies on Thrombosis in Myeloproliferative Neoplasia Patients

R. Dambrauskienė¹, R. Gerbutavičius¹, R. Vadeikienė¹, R. Gerbutavičius², R. Ugenskienė¹, M. Rudžianskienė¹, E. Juozaitytė¹, D. Remeikienė¹, R. Gerbutavičienė³, R. Paukštaitienė⁴

Abstract Number: PB0748

Anti-platelet Drugs and Risk of Intracranial Hemorrhage in Patients with Metastatic Brain Tumors

E. Miller¹, R. Patell², E. Uhlmann³, S. Ren⁴, H. Southard², P. Elavalakanar², G. Weber⁵, D. Neuberg⁴, J. Zwicker²

Abstract Number: PB0754

Antiplatelet and Cytostatic Properties of Nilotinib Synthetic Analogues

L.M. Pechlivani¹, N. Ntemou², P. Voulgari², D. Pantazi¹, K. Skobridis², A.D. Tselepis¹

Abstract Number: LPB0072

Aspirin vs P2RY12-Inhibitors to Reduce Cancer Associated Thrombosis and Tumor Growth in Digestive Cancers

A.L. Palacios Acedo¹, S. Mezouar¹, D. Mege^1,2, L. Crescence¹, C. Dubois¹, L. Panicot-Dubois¹

Abstract Number: PB0753

Association of Platelet Count and Coagulopathy before, during and Post Chemotherapy: Is it Worth Doing?

N. Anwar¹, N. Fatima¹, H.-u. Mujtaba¹, T. Shamsi¹

Abstract Number: PB0755

Characteristics and Management of a Series of TAFRO Syndrome

X. Ye¹

Abstract Number: PB0752

Chemotherapy Induced Thrombocytopenia: Is it Inducing Additional Social, Economic and Clinical Burden?

N. Anwar¹, N. Fatima¹, H.-u.- Mujtaba¹, T. Shamsi¹

Abstract Number: PB0757

Chemotherapy-induced Thrombocytopenia and Platelet Transfusions in Hematology/Oncology Practice

L. Hambardzumyan^1,2, A. Movsisyan^1,2, M. Badikyan^2,3, N. Martirosyan^2,3, H. Khachatryan^1,2, A. Sevoyan², H. Grigoryan^1,1,2, N. Martirosyan^2,4, G. Tamamyan^1,2,4, S. Danielyan²

Abstract Number: PB0756

Chronic Myeloid Leukemia with Extreme Thrombocytosis as Unusual Initial Presentation

N. Petkova¹

Abstract Number: LPB0120

Correlation between Procoagulant Platelets and Hypercoagulability in Lung Cancer Patients

M. Schreuder^1,2, E.E. Ramsay^1,2, H. Campbell³, J. Simes¹, M. Boyer⁴, A. Joshua^5,6,7, V. Chin^5,6,7, J. Young^8,9,10, B. Brown², V.M. Chen^3,11, P.J. Hogg^2,12

Abstract Number: PB0750

Correlation between Serum PDGF-CC Levels with Clinical Stage of Colorectal Cancer

E. Sundarita¹, M. Syahrir¹, N. Djamaludin¹, Y.D. Andayani¹, Z. Zulaikha¹, E. Syahriana¹

Abstract Number: PO151

Essential Thrombocythemia with Deep Vein Thrombosis and Recurrent Gangrene Pedis

H. Gustian¹.

Abstract Number: PB0758

Hemostatic Evaluation by Thromboelastography in Patients from a Peruvian Oncologic Center

L.F. Motta Rosada¹, R.M. Rodriguez Torres¹, N.V. Herrera Valverde²

Abstract Number: PB0749

Native Rotational Thromboelastometry in Chemotherapy Induced Thrombocytopenia

A.-M. Hulshof¹, F. Heubel-Moenen¹, F. Tjahjadi², C. Saelmans², T. van de Berg², E. Beckers¹, T. Hackeng², Y. Henskens¹

Abstract Number: OC 41.1

Platelet microRNAs Inhibit Primary Tumor Growth via Broad Modulation of Tumor Cell mRNA Expression in Ectopic Pancreatic Cancer in Mice

J.G. Wurtzel¹, S. Lazar¹, I. Astsaturov², A.S. Weyrich³, J.W. Rowley³, L. Goldfinger¹

Abstract Number: PB0747

Platelets Promoted Malignancy Involving Exosomal HMGB1

J.-D. Wang¹, C.-J. Chen¹, S.-L. Liao¹, S.-W. Huang²

Abstract Number: OC 58.4

Platelets Stimulate Programmed Death-ligand 1 Expression by Cancer Cells: Inhibition by Anti-platelet Drugs

A. Asgari¹, G. Lesyk¹, E. Poitras², N. Govindasamy³, K. Terry², R. To¹, V. Back¹, J. Rudzinski³, J. Lewis³, P. Jurasz^1,2

Abstract Number: LPB0121

Quantitative and Qualitative Changes in Platelet Traits of Sunitinib-treated Patients with Renal Cell Carcinoma in Relation to Circulating Sunitinib Levels: A Proof-of-Concept Study

B.M. Tullemans¹, S.L. Brouns¹, F. Swieringa¹, S. Sabrkhany¹, F.W. van den Berkmortel², N.A. Peters³, P. de Bruijn⁴, S.L. Koolen^4,5, J.W. Heemskerk¹, M.J. Aarts⁶, M.J. Kuijpers¹

Abstract Number: OC 58.1

The “Double-edged Sword”: The Role of LMWPTP in Platelet Hyperactivity in Cancer Patients

A.V.S. Faria^1,2, B. Yu², S.S. Andrade³, M. Peppelenbosch², G. Fuhler², C.V. Ferreira-Halder¹

Abstract Number: PB0746

Tumor Cell-induced Platelet Aggregation is Sustained by Platelet Entrapment into the Fibrin Network Formed by Thrombin

I. Tesakov¹, A. Filkova^2,3,4, A. Deputatova⁴, A. Korneichuk⁴, S. Obydennyi^2,3, I. Kireev⁵, M. Panteleev^2,3,4, A. Sveshnikova^2,3,4